Square Pharmaceuticals PLC. (DSE:SQURPHARMA)

DSE:SQURPHARMA Revenue

Square Pharmaceuticals PLC. had revenue of 21.70B BDT in the quarter ending March 31, 2026, with 7.82% growth. This brings the company's total for the last twelve months to 83.53B, up 10.11% year-over-year. In the fiscal year ending June 30, 2025, Square Pharmaceuticals PLC. had annual revenue of 76.29B with 8.83% growth. That makes Square Pharmaceuticals PLC. the 9,513th largest company in the world by revenue and 8th in Bangladesh.

• Revenue (ttm): 83.53B
• Revenue Growth: +10.11%
• P/S Ratio: 2.33
• Revenue / Employee: 5.24M
• Employees: 15,937
• Market Cap: 194.66B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Bangladesh 88.90B 97.2%
• Export 2.55B 2.8%

Fiscal year ended Jun 30, 2025 See the full DSE:SQURPHARMA breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	76.29B	6.19B	8.83%
Jun 30, 2024	70.10B	9.39B	15.47%
Jun 30, 2023	60.71B	3.11B	5.40%
Jun 30, 2022	57.60B	6.89B	13.60%
Jun 30, 2021	50.70B	4.83B	10.52%

Data Source: S&P Global Market Intelligence Last updated: Apr 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error